-
Featured
Low-risk Incidental Prostate Cancer in Men with Bladder Cancer May Be Associated with Longer Survival
Men with bladder cancer who have low-risk prostate cancer detected incidentally by radical cystoprostatectomy may actually have a more favorable prognosis than those who do not.
-
Featured
Ultrasound Therapy Yields Promising Results for Localized Prostate Cancer
At the American Urological Association's 2019 Annual Meeting, researchers presented the findings of a study on the effects transurethral ultrasound ablation (TULSA), a novel minimally invasive procedure that can reduce prostate size and prostate-specific antigens in patients with localized prostate cancer.
-
Featured
New Target Discovered for Prostate Cancer Immunotherapy
Genitourinary pathologists at Massachusetts General Hospital are the first to demonstrate that PD-L1 expression is highly prevalent in prostate tumor-associated nerves. Such nerves may represent an important target for immunotherapy regimens.
-
New Research Indicates Promising Future for Prostate Cancer Diagnosis
Research conducted by Dr. Adam Feldman, Dr. Leo Cheng, and colleagues shows promising results for a non-invasive technique detecting metabolic signature between benign and cancerous prostate tissue.
-
Prostate Cancer and Translational Research
Douglas Middleton Dahl, MD, is chief of the Division of Urologic Oncology at Massachusetts General Hospital, as well as director of Robotic Surgery. In this video, he discusses his translational research on prostate cancer cells and explains how this work will advance patient care.
-
Advancing Genetic Testing for Prostate Cancer
The Prostate Cancer High-Risk Clinic from the Massachusetts General Hospital Department of Urology and the Mass General Cancer Center, offers advanced genetic testing and cancer screening, and expands insights on the genetics of prostate cancer.
Prostate Cancer contributors
-
Adam Scott Feldman, MD, MPH
Director, Combined Harvard Urologic Oncology Fellowship, Urologic Oncologist, Department of Urology, Massachusetts General Hospital
Recent Article
New Research Indicates Promising Future for Prostate Cancer Diagnosis
-
Chin-Lee Wu, MD, PhD
Associate Pathologist, Massachusetts General Hospital and Mass General Cancer Center, Associate Professor of Pathology, Harvard Medical School, Director, Genitourinary Pathology Services
Recent Article
New Research Indicates Promising Future for Prostate Cancer Diagnosis
-
Douglas Middleton Dahl, MD
Chief, Division of Urologic Oncology, Director of Robotic Surgery, Associate Professor, Harvard Medical School
Recent Article
Prostate Cancer and Translational Research
-
Mass General Bladder, Kidney, Penile, Prostate and Testicular Cancer Program
Physicians in the Mass General Bladder, Kidney, Penile, Prostate and Testicular Cancer Program specialize in using advanced surgical therapies and minimally invasive procedures to treat male and female genitourinary cancers.
